Drug Firms Targeting Smaller Deals

After the collapse of a potential pharmaceutical megadeal last week, drug companies are signing smaller deals to give greater focus to their businesses.



from WSJ.com: US Business http://ift.tt/1rC9EsV

via IFTTT